Aldeyra shows FDA-rejected reproxalap improves eye discomfort in new phase 3 study 08.08.2024 17:56 Fiercebiotech.com Aldeyra shows FDA-rejected reproxalap improves eye discomfort in new phase 3 study gmasson Thu, 08/08/2024 - 10:56
